Elixinol Financial Statements From 2010 to 2024
| ELLXF Stock | USD 0.01 0.02 80.47% |
Check Elixinol Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elixinol Global's main balance sheet or income statement drivers, such as , as well as many indicators such as . Elixinol financial statements analysis is a perfect complement when working with Elixinol Global Valuation or Volatility modules.
Elixinol |
Elixinol Global Company Operating Margin Analysis
Elixinol Global's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Elixinol Global Operating Margin | (1.63) % |
Most of Elixinol Global's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elixinol Global is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Elixinol Global has an Operating Margin of -1.6331%. This is 95.34% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 70.36% lower than that of the firm.
Elixinol Global Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elixinol Global's current stock value. Our valuation model uses many indicators to compare Elixinol Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elixinol Global competition to find correlations between indicators driving Elixinol Global's intrinsic value. More Info.Elixinol Global is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elixinol Global's earnings, one of the primary drivers of an investment's value.About Elixinol Global Financial Statements
Elixinol Global stakeholders use historical fundamental indicators, such as Elixinol Global's revenue or net income, to determine how well the company is positioned to perform in the future. Although Elixinol Global investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elixinol Global's assets and liabilities are reflected in the revenues and expenses on Elixinol Global's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elixinol Global. Please read more on our technical analysis and fundamental analysis pages.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. Elixinol Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Elixinol Pink Sheet
Elixinol Global financial ratios help investors to determine whether Elixinol Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Global security.